Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Treatment of bleeding complications in patients on anticoagulant therapy

Piran, Siavash, Schulman, Sam · 2019 · Blood

Abstract

Anticoagulant therapy is often refrained from out of fear of hemorrhagic complications. The most frequent type of major bleeding is gastrointestinal, but intracranial hemorrhage has the worst prognosis. Management of these complications in patients on anticoagulants should follow the same routines as for nonanticoagulated patients, as described here with the previously mentioned bleeds as examples. In addition, for life-threatening or massive hemorrhages, reversal of the anticoagulant effect is also crucial. Adequate reversal requires information on which anticoagulant the patient has taken and when the last dose was ingested. Laboratory data can be of some help, but not for all anticoagulants in the emergency setting. This is reviewed here for the different types of anticoagulants: vitamin K antagonists, heparins, fondaparinux, thrombin inhibitors and factor Xa inhibitors. Specific antidotes for the latter are becoming available, but supportive care and nonspecific support for hemostasis with antifibrinolytic agents or prothrombin complex concentrates, which are widely available, should be kept in mind.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2018-06-820746

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 75 references

Research works printed but not linked: 3

  1. Connolly, Interim Report on the ANNEXA-4 Study: andexanet for reversal of anticoagulation in factor Xa - associated acute major bleeding
  2. Piran, 2018, Reversal of direct factor Xa inhibitor-associated major bleeding with four-factor prothrombin complex concentrate: a systematic review and meta-analysis, Res Pract Thromb Haemost, 2, PB449
  3. UPMC System Pharmacy and Therapeutic Committee Formulary Review. Prothrombin complex concentrate (human) (Kcentra®, CSL Behring LLC). Available at: https://emcrit.org/wp-content/uploads/2013/12/Kcentra_4FPCC_SPT.pdf. Accessed 20 December 2018.

Cited by

See all 114

Metadata

Authors
Piran, S., & Schulman, S.
Affiliations
  • Thrombosis and Atherosclerosis Research Institute (CA)
  • Sechenov University (RU)
Venue
Blood
Published
2019-01-31
Volume
133
Issue
5
Pages
425-435
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2904680572
Cited by
108
References
75
Citations by year
2026: 10 · 2025: 13 · 2024: 17 · 2023: 18 · 2022: 24 · 2021: 12 · 2020: 10 · 2019: 4
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
Keywords
anticoagulant-induced bleeding, bleeding complications, anticoagulant reversal, vitamin K antagonists, heparin, fondaparinux, thrombin inhibitors, factor Xa inhibitors, intracranial hemorrhage, gastrointestinal bleeding, antifibrinolytic agents, prothrombin complex concentrate, emergency management
MeSH terms
Anticoagulants, Antithrombins, Hemorrhage, Heparin, Humans, Vitamin K, Disease Management, Factor Xa Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of bleeding complications in patients on anticoagulant therapy. https://app.cochat.ai/papers/10.1182/blood-2018-06-820746
The paper
Piran, S., & Schulman, S. (2019). Treatment of bleeding complications in patients on anticoagulant therapy. Blood. https://doi.org/10.1182/blood-2018-06-820746

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.